Wandercraft Partners With NSM for Exclusive Sales of Home Exoskeleton Eve

Wandercraft announced on June 25, 2026, that it had appointed NSM as the exclusive CRT sales partner for Eve, a self-balancing exoskeleton for home use. After FDA approval, NSM will handle evaluations, training and delivery through its network of more than 180 locations. Eve is designed for people with spinal cord injuries and is expected to launch in summer 2026.

Eve is an exoskeleton for use at home by people with spinal cord injuries and others with severe mobility impairments. A key point is that, after FDA approval, NSM will handle evaluations, training and delivery through more than 180 locations. Unlike Atalante X, which is used mainly in rehabilitation facilities, the partnership can be seen as establishing a distribution system that supports use at home after discharge.